Brenda M. Sandmaier

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T‐cell and natural killer‐cell lymphomas

M. Sorror, R. Storb, B. Sandmaier, 2010, British journal of haematology.

Antibody engagement of intercellular adhesion molecule 3 triggers apoptosis of normal and leukaemic myeloid marrow cells

B. Sandmaier, J. Hayflick, A. Stucki, 2000, British journal of haematology.

Pilot Study of a 213Bismuth-Labeled Anti-CD45 mAb as a Novel Nonmyeloablative Conditioning for DLA-Haploidentical Littermate Hematopoietic Transplantation

R. Storb, B. Sandmaier, D. Hamlin, 2010, Transplantation.

Evaluation of Posttransplant Methotrexate to Facilitate Engraftment in the Canine Major Histocompatibility Complex-Haploidentical Nonmyeloablative Transplant Model

R. Storb, B. Sandmaier, M. Thakar, 2010, Transplantation.

HLA-matched related (MRD) or unrelated donor (URD) nonmyeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD)

M. Maris, B. Sandmaier, D. Maloney, 2004 .

Pre‐transplant comorbidity burden and post‐transplant chronic graft‐versus‐host disease

M. Sorror, R. Storb, B. Sandmaier, 2015, British journal of haematology.

A Limited Sampling Schedule to Estimate Mycophenolic Acid Area Under the Concentration‐Time Curve in Hematopoietic Cell Transplantation Recipients

B. Sandmaier, D. Salinger, P. Vicini, 2012, Journal of clinical pharmacology.

A Phase II Trial of 90Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL).

R. Storb, B. Sandmaier, D. Maloney, 2006 .